Applicants seeking approval of Abbreviated New Drug Applications (ANDAs) in most cases must perform bioequivalence studies comparing their proposed generic product to the innovator drug listed in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback